EUVIMEDEUVIMED entdecken
Crossref

Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants

Jessica S Jay, Julie A Patterson, Yiran Zhang, Stephen C Ijioma, Norman V Carroll, David A Holdford, Richard K Sterling, Gaurav Gupta, Idris Yakubu

Journal of the American Pharmacists Association · 2023

DOI: 10.1016/j.japh.2023.06.027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2023. Verfasst von Jessica S Jay und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hepatitis C, Chronic, Kidney Transplantation, Hepatitis C. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Trials describing 4-12 week courses of direct-acting antiviral drugs (DAAs) to treat hepatitis C virus (HCV) transmission from infected donors to uninfected kidney transplant recipients (D+/R-transplants), may be limited in application by costs and delayed access to expensive DAAs. A short prophylactic strategy may be safer and cost-effective. Here, we report a cost minimization analysis using the health system perspective to determine the least expensive DAA regimen, using available published strategies. OBJECTIVES: To conduct cost-minimization analyses (CMAs) from the health system perspective of four DAA regimens to prevent and/or treat HCV transmission from D+/R-kidney transplants. METHODS: CMAs comparing 4 strategies: 1) 7-day prophylaxis with generic sofosbuvir/velpatasvir (SOF/VEL), with 12-week branded glecaprevir/pibrentasvir (G/P) for those with transmission; 2) 8-day branded G/P prophylaxis, with 12-week branded SOF/VEL/voxilaprevir for those with transmission; 3) 4-week perioperative generic SOF/VEL prophylaxis, with 12-week branded G/P for those with transmission; and 4) 8-week branded G/P "transmit-and-treat." We included data from published literature to estimate the probability of viral transmission in patients who received DAA prophylaxis, and assumed a 100% transmission rate for those who received the "transmit-and-treat" approach. RESULTS: In base-case analyses, strategies 1 (expected cost [EC]: $2326) and 2 (expected cost: $2646) were less expensive than strategies 3 (EC: $4859) and 4 (EC: $18,525). Threshold analyses for 7-day SOF/VEL versus 8-day G/P suggested that there were reasonable input levels at which the 8-day strategy may be least costly. The threshold values for the SOF/VEL prophylaxis strategies (7-day vs. 4- week) indicated that the 4-week strategy is unlikely to be less costly under any reasonable value of the input variables. CONCLUSIONS: Short duration DAA prophylaxis using 7 days of SOF/VEL or 8 days of G/P has the potential to yield significant cost savings for D+/R- kidney transplants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis C, ChronicKidney TransplantationHepatitis CHumansAntiviral AgentsHepacivirusSofosbuvirDrug Therapy, CombinationCosts and Cost AnalysisGenotypeTreatment Outcome

Substanzen

Antiviral AgentsSofosbuvir

Zitieren

APA

Jay, J. S., Patterson, J. A., Zhang, Y., Ijioma, S. C., Carroll, N. V., Holdford, D. A., Sterling, R. K., Gupta, G., & Yakubu, I. (2023). Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2023.06.027

Vancouver

Jay JS, Patterson JA, Zhang Y, Ijioma SC, Carroll NV, Holdford DA, et al. Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants. Journal of the American Pharmacists Association. 2023. doi:10.1016/j.japh.2023.06.027

BibTeX
@article{Jay2023,
  author = {Jay, Jessica S and Patterson, Julie A and Zhang, Yiran and Ijioma, Stephen C and Carroll, Norman V and Holdford, David A and Sterling, Richard K and Gupta, Gaurav and Yakubu, Idris},
  title = {Cost minimization analysis of short-duration antiviral prophylaxis for hepatitis C positive donor kidney transplants},
  journal = {Journal of the American Pharmacists Association},
  year = {2023},
  doi = {10.1016/j.japh.2023.06.027}
}
Kostenlos starten →